Eisai Pharmaceuticals plans to expand its manufacturing plant in Visakhapatnam and set up an innovation centre to support its new drug development programmes.
The Japanese drug maker sells cancer and central nervous disorder drugs in India. It has a manufacturing unit in Visakhapatnam (Vizag) which largely caters for export. The company is now expanding its presence in the country with new product launches and is investing in plant expansion.
"We have a facility to manufacture two billion capsules annually. We are ramping up our active pharmaceutical ingredients (APIs) manufacturing unit and developing an innovation centre for new formulations at Visakhapatnam,"